Business / Finance

RSS

Delcath receives ISO 13485 Certification for Galway facility

Delcath Systems, Inc. today announced that the Company's Galway, Ireland location has achieved ISO 13485:2003 Certification—an internationally recognized quality standard designed to ensure that medical device manufacturers have the necessary comprehensive quality management systems in place to safely design, develop, manufacture and distribute medical devices in the European Union.

28 Dec 2011

Concord Medical provides update on Chang'an Hospital acquisition

Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, today updated its progress on the pending acquisition of Chang'an Hospital.

28 Dec 2011

Nano3D's technology and revenues continue to impress RBCC

As Rainbow Coral Corp. continues its due diligence on Nano3D Biosciences (n3D), it's not just the early-stage biotech firm's groundbreaking technology that has impressed RBCC—It's also n3D's revenues.

28 Dec 2011

Weikang relocates to own headquarters building

Weikang Bio-Technology Group, Inc. Completes HQ Relocation After Purchasing Building For $14 Million And Answers Questions About Its Third Quarter Financials

28 Dec 2011

National Mentor Holdings fourth quarter revenue increases 5.0% to $271.5 million

National Mentor Holdings, Inc. today announced its financial results for the fourth quarter and fiscal year ended September 30, 2011.

27 Dec 2011

Hard Candy Fitness Moscow Center opens for workouts

Madonna in partnership with her manager Guy Oseary and Mark Mastrov, Chairman of New Evolution Ventures (NeV), announced their second Hard Candy Fitness Center in Moscow is now open for workouts.

26 Dec 2011

Wolters Kluwer sells pharma-related business to Springer Science+Business Media

Wolters Kluwer, a market-leading global information services company focused on professionals, today announced that it has completed the sale of its pharma-related Marketing & Publishing Services business to Springer Science+Business Media.

26 Dec 2011

CEL-SCI reports net loss of $26.8M for fiscal year ended September 30, 2011

CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2011.

26 Dec 2011

Acceleron Pharma raises $30 million through private financing

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, today announced it raised a $30M private financing.

23 Dec 2011

Lexicon completes rights offering

Lexicon Pharmaceuticals, Inc. announced today that it has completed its previously announced rights offering pursuant to an effective shelf registration statement.

23 Dec 2011

Veloxis, Athena partner to establish competitive presence for AtorFen in emerging markets

Veloxis Pharmaceuticals and Athena Drug Delivery Solutions Pvt. Ltd. today announced an alliance whereby Athena will obtain exclusive rights in certain emerging market territories to manufacture and, with third parties, develop, register and commercialize Veloxis' AtorFen (Fenofibrate Atorvastatin fixed dose combination).

23 Dec 2011

Walgreen expecting sharp drop in prescription business

A contract dispute with pharmacy benefit manager Express Scripts is likely to cut the number of drugs Walgreen will sell.

23 Dec 2011

ViroPharma to acquire Meritage

ViroPharma Incorporated today announced that it has entered into an exclusive option to acquire Meritage Pharma, Inc., a private company based in San Diego, CA focused on developing oral budesonide suspension (OBS) as a treatment for eosinophilic esophagitis (EoE), a chronic inflammatory disorder of the esophagus.

23 Dec 2011

Tunstall completes acquisition of AMAC

Following the announcement on 22 September 2011, American Medical Alert Corp, a leading provider of remote health monitoring and 24/7 communication services that enhance care, accelerate response times, improve operational effectiveness and deliver sustainable patient services, is pleased to announce today the completion of its acquisition by Tunstall Healthcare Group, a leading telehealth and telecare provider based in the UK.

23 Dec 2011

Agilent acquires BioSystem Development business

Agilent Technologies Inc. today announced it has completed the acquisition of the BioSystem Development business. BioSystem Development is a privately held company that develops and manufactures the AssayMAP Microchromatography platform to meet the analytical needs of the life sciences industry.

22 Dec 2011

Mazor Robotics announces purchase agreement with NSH Michigan

Mazor Robotics Ltd, the leader in innovative surgical robots and complementary products for spine surgery, announced a purchase agreement with NSH Michigan, Inc.

21 Dec 2011

Takeda enters agreement to acquire Intellikine

Takeda Pharmaceutical Company Limited and Intellikine, Inc. today announced that Takeda America Holdings, Inc., a wholly-owned subsidiary of Takeda, and Intellikine, a privately-held company focused on the discovery and development of innovative, small molecule drugs, have entered into an agreement for Takeda America Holdings to acquire Intellikine by cash.

21 Dec 2011

Osteologix declares dividend of Euro 0.06 per share

Osteologix Holdings, PLC declared a dividend of Euro 0.06 per sharepayable to shareholders of record on December 19, 2011. The payment date will be February 15, 2012.

20 Dec 2011

Atox Bio to advance AB103 Phase 2 study with $3.25M financing

Atox Bio, developer of therapeutics for diseases mediated by an excessive inflammatory response, today announced that it has raised $3.25 million in an initial closing. The investment was co-led by Esperante and a private US-based investor and will be used to advance AB103, currently in phase 2 clinical studies for the treatment of Necrotizing Soft Tissue Infections (NSTI).

19 Dec 2011

Cohera Medical secures over $25 million in Series C financing through private investors

Cohera Medical, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has secured over $25 million Series C financing through private investors. A total of $16.5 million was raised through existing investors and over $9 million was raised through new investors, which significantly bolstered the round.

19 Dec 2011